Search

Your search keyword '"Foschi, F.G."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Foschi, F.G." Remove constraint Author: "Foschi, F.G." Database OpenAIRE Remove constraint Database: OpenAIRE
29 results on '"Foschi, F.G."'

Search Results

1. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery

2. Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

3. Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?

4. Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

5. Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma

6. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

7. Pattern of macrovascular invasion in hepatocellular carcinoma

8. Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter

9. Identification of clinical phenotypes and related survival in patients with large hccs

10. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

11. Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib

12. Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients

13. Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

14. Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

15. Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3)

16. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

17. Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients

18. Platelets and hepatocellular cancer: Bridging the bench to the clinics

19. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

20. The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study

21. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study

22. Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older

23. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

24. Real-Time Contrast-Enhanced Ultrasound – a New Simple Tool for Detection of Peritoneal-Pleural Communications in Hepatic Hydrothorax

25. Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice

26. Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study

27. Focal nodular hyperplasia after busulfan treatment

28. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection

29. Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis

Catalog

Books, media, physical & digital resources